ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Trastuzumab Monoclonal Antibody Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-28U14352
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Trastuzumab Monoclonal Antibody Market Research Report 2023
BUY CHAPTERS

Global Trastuzumab Monoclonal Antibody Market Research Report 2025

Code: QYRE-Auto-28U14352
Report
May 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Amgen Inc
Organon
TEVA
Viatris
Pfizer Inc

Trastuzumab Monoclonal Antibody Market Size

The global market for Trastuzumab Monoclonal Antibody was valued at US$ 4964 million in the year 2024 and is projected to reach a revised size of US$ 6860 million by 2031, growing at a CAGR of 4.8% during the forecast period.

Trastuzumab Monoclonal Antibody Market

Trastuzumab Monoclonal Antibody Market

Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer.
North American market for Trastuzumab Monoclonal Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Trastuzumab Monoclonal Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Trastuzumab Monoclonal Antibody include Roche, Amgen, Pfizer, Organon, Teva, Viatris, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Trastuzumab Monoclonal Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Trastuzumab Monoclonal Antibody.
The Trastuzumab Monoclonal Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Trastuzumab Monoclonal Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Trastuzumab Monoclonal Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Trastuzumab Monoclonal Antibody Market Report

Report Metric Details
Report Name Trastuzumab Monoclonal Antibody Market
Accounted market size in year US$ 4964 million
Forecasted market size in 2031 US$ 6860 million
CAGR 4.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Breast Cancer
  • Stomach Cancer
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Amgen, Pfizer, Organon, Teva, Viatris
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Trastuzumab Monoclonal Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Trastuzumab Monoclonal Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Trastuzumab Monoclonal Antibody Market growing?

Ans: The Trastuzumab Monoclonal Antibody Market witnessing a CAGR of 4.8% during the forecast period 2025-2031.

What is the Trastuzumab Monoclonal Antibody Market size in 2031?

Ans: The Trastuzumab Monoclonal Antibody Market size in 2031 will be US$ 6860 million.

Who are the main players in the Trastuzumab Monoclonal Antibody Market report?

Ans: The main players in the Trastuzumab Monoclonal Antibody Market are Roche, Amgen, Pfizer, Organon, Teva, Viatris

What are the Application segmentation covered in the Trastuzumab Monoclonal Antibody Market report?

Ans: The Applications covered in the Trastuzumab Monoclonal Antibody Market report are Breast Cancer, Stomach Cancer

What are the Type segmentation covered in the Trastuzumab Monoclonal Antibody Market report?

Ans: The Types covered in the Trastuzumab Monoclonal Antibody Market report are Brand, Biosimilar

Recommended Reports

Monoclonal Antibodies

Cancer Antibody Therapy

Breast Cancer Markets

1 Trastuzumab Monoclonal Antibody Market Overview
1.1 Product Definition
1.2 Trastuzumab Monoclonal Antibody by Type
1.2.1 Global Trastuzumab Monoclonal Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Brand
1.2.3 Biosimilar
1.3 Trastuzumab Monoclonal Antibody by Application
1.3.1 Global Trastuzumab Monoclonal Antibody Market Value by Application (2024 VS 2031)
1.3.2 Breast Cancer
1.3.3 Stomach Cancer
1.4 Global Trastuzumab Monoclonal Antibody Market Size Estimates and Forecasts
1.4.1 Global Trastuzumab Monoclonal Antibody Revenue 2020-2031
1.4.2 Global Trastuzumab Monoclonal Antibody Sales 2020-2031
1.4.3 Global Trastuzumab Monoclonal Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Trastuzumab Monoclonal Antibody Market Competition by Manufacturers
2.1 Global Trastuzumab Monoclonal Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global Trastuzumab Monoclonal Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Trastuzumab Monoclonal Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Trastuzumab Monoclonal Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Trastuzumab Monoclonal Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Trastuzumab Monoclonal Antibody, Product Type & Application
2.7 Global Key Manufacturers of Trastuzumab Monoclonal Antibody, Date of Enter into This Industry
2.8 Global Trastuzumab Monoclonal Antibody Market Competitive Situation and Trends
2.8.1 Global Trastuzumab Monoclonal Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Trastuzumab Monoclonal Antibody Players Market Share by Revenue
2.8.3 Global Trastuzumab Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Trastuzumab Monoclonal Antibody Market Scenario by Region
3.1 Global Trastuzumab Monoclonal Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Trastuzumab Monoclonal Antibody Sales by Region: 2020-2031
3.2.1 Global Trastuzumab Monoclonal Antibody Sales by Region: 2020-2025
3.2.2 Global Trastuzumab Monoclonal Antibody Sales by Region: 2026-2031
3.3 Global Trastuzumab Monoclonal Antibody Revenue by Region: 2020-2031
3.3.1 Global Trastuzumab Monoclonal Antibody Revenue by Region: 2020-2025
3.3.2 Global Trastuzumab Monoclonal Antibody Revenue by Region: 2026-2031
3.4 North America Trastuzumab Monoclonal Antibody Market Facts & Figures by Country
3.4.1 North America Trastuzumab Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Trastuzumab Monoclonal Antibody Sales by Country (2020-2031)
3.4.3 North America Trastuzumab Monoclonal Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Trastuzumab Monoclonal Antibody Market Facts & Figures by Country
3.5.1 Europe Trastuzumab Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Trastuzumab Monoclonal Antibody Sales by Country (2020-2031)
3.5.3 Europe Trastuzumab Monoclonal Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Trastuzumab Monoclonal Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Trastuzumab Monoclonal Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Trastuzumab Monoclonal Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific Trastuzumab Monoclonal Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Trastuzumab Monoclonal Antibody Market Facts & Figures by Country
3.7.1 Latin America Trastuzumab Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Trastuzumab Monoclonal Antibody Sales by Country (2020-2031)
3.7.3 Latin America Trastuzumab Monoclonal Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Trastuzumab Monoclonal Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Trastuzumab Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Trastuzumab Monoclonal Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa Trastuzumab Monoclonal Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Trastuzumab Monoclonal Antibody Sales by Type (2020-2031)
4.1.1 Global Trastuzumab Monoclonal Antibody Sales by Type (2020-2025)
4.1.2 Global Trastuzumab Monoclonal Antibody Sales by Type (2026-2031)
4.1.3 Global Trastuzumab Monoclonal Antibody Sales Market Share by Type (2020-2031)
4.2 Global Trastuzumab Monoclonal Antibody Revenue by Type (2020-2031)
4.2.1 Global Trastuzumab Monoclonal Antibody Revenue by Type (2020-2025)
4.2.2 Global Trastuzumab Monoclonal Antibody Revenue by Type (2026-2031)
4.2.3 Global Trastuzumab Monoclonal Antibody Revenue Market Share by Type (2020-2031)
4.3 Global Trastuzumab Monoclonal Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global Trastuzumab Monoclonal Antibody Sales by Application (2020-2031)
5.1.1 Global Trastuzumab Monoclonal Antibody Sales by Application (2020-2025)
5.1.2 Global Trastuzumab Monoclonal Antibody Sales by Application (2026-2031)
5.1.3 Global Trastuzumab Monoclonal Antibody Sales Market Share by Application (2020-2031)
5.2 Global Trastuzumab Monoclonal Antibody Revenue by Application (2020-2031)
5.2.1 Global Trastuzumab Monoclonal Antibody Revenue by Application (2020-2025)
5.2.2 Global Trastuzumab Monoclonal Antibody Revenue by Application (2026-2031)
5.2.3 Global Trastuzumab Monoclonal Antibody Revenue Market Share by Application (2020-2031)
5.3 Global Trastuzumab Monoclonal Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Trastuzumab Monoclonal Antibody Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Trastuzumab Monoclonal Antibody Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Trastuzumab Monoclonal Antibody Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Organon
6.4.1 Organon Company Information
6.4.2 Organon Description and Business Overview
6.4.3 Organon Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Organon Trastuzumab Monoclonal Antibody Product Portfolio
6.4.5 Organon Recent Developments/Updates
6.5 Teva
6.5.1 Teva Company Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Trastuzumab Monoclonal Antibody Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Viatris
6.6.1 Viatris Company Information
6.6.2 Viatris Description and Business Overview
6.6.3 Viatris Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Viatris Trastuzumab Monoclonal Antibody Product Portfolio
6.6.5 Viatris Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Trastuzumab Monoclonal Antibody Industry Chain Analysis
7.2 Trastuzumab Monoclonal Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Trastuzumab Monoclonal Antibody Production Mode & Process Analysis
7.4 Trastuzumab Monoclonal Antibody Sales and Marketing
7.4.1 Trastuzumab Monoclonal Antibody Sales Channels
7.4.2 Trastuzumab Monoclonal Antibody Distributors
7.5 Trastuzumab Monoclonal Antibody Customer Analysis
8 Trastuzumab Monoclonal Antibody Market Dynamics
8.1 Trastuzumab Monoclonal Antibody Industry Trends
8.2 Trastuzumab Monoclonal Antibody Market Drivers
8.3 Trastuzumab Monoclonal Antibody Market Challenges
8.4 Trastuzumab Monoclonal Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roche
Amgen Inc
Organon
TEVA
Viatris
Pfizer Inc
List of Tables
 Table 1. Global Trastuzumab Monoclonal Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Trastuzumab Monoclonal Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Trastuzumab Monoclonal Antibody Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Trastuzumab Monoclonal Antibody Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Trastuzumab Monoclonal Antibody Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Trastuzumab Monoclonal Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Trastuzumab Monoclonal Antibody Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Trastuzumab Monoclonal Antibody Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Trastuzumab Monoclonal Antibody, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Trastuzumab Monoclonal Antibody, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Trastuzumab Monoclonal Antibody, Product Type & Application
 Table 12. Global Key Manufacturers of Trastuzumab Monoclonal Antibody, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Trastuzumab Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trastuzumab Monoclonal Antibody as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Trastuzumab Monoclonal Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Trastuzumab Monoclonal Antibody Sales by Region (2020-2025) & (K Units)
 Table 18. Global Trastuzumab Monoclonal Antibody Sales Market Share by Region (2020-2025)
 Table 19. Global Trastuzumab Monoclonal Antibody Sales by Region (2026-2031) & (K Units)
 Table 20. Global Trastuzumab Monoclonal Antibody Sales Market Share by Region (2026-2031)
 Table 21. Global Trastuzumab Monoclonal Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Trastuzumab Monoclonal Antibody Revenue Market Share by Region (2020-2025)
 Table 23. Global Trastuzumab Monoclonal Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Trastuzumab Monoclonal Antibody Revenue Market Share by Region (2026-2031)
 Table 25. North America Trastuzumab Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Trastuzumab Monoclonal Antibody Sales by Country (2020-2025) & (K Units)
 Table 27. North America Trastuzumab Monoclonal Antibody Sales by Country (2026-2031) & (K Units)
 Table 28. North America Trastuzumab Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Trastuzumab Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Trastuzumab Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Trastuzumab Monoclonal Antibody Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Trastuzumab Monoclonal Antibody Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Trastuzumab Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Trastuzumab Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Trastuzumab Monoclonal Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Trastuzumab Monoclonal Antibody Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Trastuzumab Monoclonal Antibody Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Trastuzumab Monoclonal Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Trastuzumab Monoclonal Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Trastuzumab Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Trastuzumab Monoclonal Antibody Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Trastuzumab Monoclonal Antibody Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Trastuzumab Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Trastuzumab Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Trastuzumab Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Trastuzumab Monoclonal Antibody Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Trastuzumab Monoclonal Antibody Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Trastuzumab Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Trastuzumab Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Trastuzumab Monoclonal Antibody Sales (K Units) by Type (2020-2025)
 Table 51. Global Trastuzumab Monoclonal Antibody Sales (K Units) by Type (2026-2031)
 Table 52. Global Trastuzumab Monoclonal Antibody Sales Market Share by Type (2020-2025)
 Table 53. Global Trastuzumab Monoclonal Antibody Sales Market Share by Type (2026-2031)
 Table 54. Global Trastuzumab Monoclonal Antibody Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Trastuzumab Monoclonal Antibody Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Trastuzumab Monoclonal Antibody Revenue Market Share by Type (2020-2025)
 Table 57. Global Trastuzumab Monoclonal Antibody Revenue Market Share by Type (2026-2031)
 Table 58. Global Trastuzumab Monoclonal Antibody Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Trastuzumab Monoclonal Antibody Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Trastuzumab Monoclonal Antibody Sales (K Units) by Application (2020-2025)
 Table 61. Global Trastuzumab Monoclonal Antibody Sales (K Units) by Application (2026-2031)
 Table 62. Global Trastuzumab Monoclonal Antibody Sales Market Share by Application (2020-2025)
 Table 63. Global Trastuzumab Monoclonal Antibody Sales Market Share by Application (2026-2031)
 Table 64. Global Trastuzumab Monoclonal Antibody Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Trastuzumab Monoclonal Antibody Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Trastuzumab Monoclonal Antibody Revenue Market Share by Application (2020-2025)
 Table 67. Global Trastuzumab Monoclonal Antibody Revenue Market Share by Application (2026-2031)
 Table 68. Global Trastuzumab Monoclonal Antibody Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Trastuzumab Monoclonal Antibody Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Trastuzumab Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Trastuzumab Monoclonal Antibody Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Amgen Company Information
 Table 76. Amgen Description and Business Overview
 Table 77. Amgen Trastuzumab Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Amgen Trastuzumab Monoclonal Antibody Product
 Table 79. Amgen Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Trastuzumab Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Trastuzumab Monoclonal Antibody Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Organon Company Information
 Table 86. Organon Description and Business Overview
 Table 87. Organon Trastuzumab Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Organon Trastuzumab Monoclonal Antibody Product
 Table 89. Organon Recent Developments/Updates
 Table 90. Teva Company Information
 Table 91. Teva Description and Business Overview
 Table 92. Teva Trastuzumab Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teva Trastuzumab Monoclonal Antibody Product
 Table 94. Teva Recent Developments/Updates
 Table 95. Viatris Company Information
 Table 96. Viatris Description and Business Overview
 Table 97. Viatris Trastuzumab Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Viatris Trastuzumab Monoclonal Antibody Product
 Table 99. Viatris Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Trastuzumab Monoclonal Antibody Distributors List
 Table 103. Trastuzumab Monoclonal Antibody Customers List
 Table 104. Trastuzumab Monoclonal Antibody Market Trends
 Table 105. Trastuzumab Monoclonal Antibody Market Drivers
 Table 106. Trastuzumab Monoclonal Antibody Market Challenges
 Table 107. Trastuzumab Monoclonal Antibody Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Trastuzumab Monoclonal Antibody
 Figure 2. Global Trastuzumab Monoclonal Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Trastuzumab Monoclonal Antibody Market Share by Type: 2024 & 2031
 Figure 4. Brand Product Picture
 Figure 5. Biosimilar Product Picture
 Figure 6. Global Trastuzumab Monoclonal Antibody Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Trastuzumab Monoclonal Antibody Market Share by Application: 2024 & 2031
 Figure 8. Breast Cancer
 Figure 9. Stomach Cancer
 Figure 10. Global Trastuzumab Monoclonal Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Trastuzumab Monoclonal Antibody Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Trastuzumab Monoclonal Antibody Sales (2020-2031) & (K Units)
 Figure 13. Global Trastuzumab Monoclonal Antibody Average Price (US$/Unit) & (2020-2031)
 Figure 14. Trastuzumab Monoclonal Antibody Report Years Considered
 Figure 15. Trastuzumab Monoclonal Antibody Sales Share by Manufacturers in 2024
 Figure 16. Global Trastuzumab Monoclonal Antibody Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Trastuzumab Monoclonal Antibody Players: Market Share by Revenue in Trastuzumab Monoclonal Antibody in 2024
 Figure 18. Trastuzumab Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Trastuzumab Monoclonal Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Trastuzumab Monoclonal Antibody Sales Market Share by Country (2020-2031)
 Figure 21. North America Trastuzumab Monoclonal Antibody Revenue Market Share by Country (2020-2031)
 Figure 22. United States Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Trastuzumab Monoclonal Antibody Sales Market Share by Country (2020-2031)
 Figure 25. Europe Trastuzumab Monoclonal Antibody Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Trastuzumab Monoclonal Antibody Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Trastuzumab Monoclonal Antibody Revenue Market Share by Region (2020-2031)
 Figure 33. China Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Trastuzumab Monoclonal Antibody Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Trastuzumab Monoclonal Antibody Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Trastuzumab Monoclonal Antibody Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Trastuzumab Monoclonal Antibody Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Trastuzumab Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Trastuzumab Monoclonal Antibody by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Trastuzumab Monoclonal Antibody by Type (2020-2031)
 Figure 52. Global Trastuzumab Monoclonal Antibody Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Trastuzumab Monoclonal Antibody by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Trastuzumab Monoclonal Antibody by Application (2020-2031)
 Figure 55. Global Trastuzumab Monoclonal Antibody Price (US$/Unit) by Application (2020-2031)
 Figure 56. Trastuzumab Monoclonal Antibody Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Herceptin Trastuzumab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Herceptin Trastuzumab Market Research Report 2024
Global HER2 Antibody Market Research Report 2025
Trastuzumab Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Herceptin Biosimilar Market Insights Forecast to 2030
Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024
Global Monoclonal Antibody for Gastric Cancer Market Research Report 2024
Global Mono Antibody mAb for HER2 Positive Advanced Breast Cancer Market Research Report 2024
Trastuzumab Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Market Research Report 2024
Global HER2 Human Epidermal Growth Factor Receptor 2 Antibody Market Research Report 2024
Global Trastuzumab Market Research Report 2025
Global Cancer Monoclonal Antibody Partnering Terms and Agreements Market Insights Forecast to 2030
Global Stomach Cancer Drugs Market Insights Forecast to 2030
Global Anti HER2 Therapy Market Research Report 2025
Global Conjugated Monoclonal Antibodies Market Research Report 2024
Global HER2 Tumor Marker Testing Market Research Report 2024
Global Hepatocellular Carcinoma Monoclonal Antibody Market Research Report 2025
Rituximab Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions